Latest Announcements

Tribhovandas Bhimji Zaveri Limited has informed BSE about Intimation on Agreements.

Esha Media Research Ltd has entered into a platform design, development, deployment and maintenance agreement with LivingAI Solution LLP for an AI-powered enterprise-grade media intelligence, reputation management and actionable feedback platform.

Interarch Building Solutions Ltd has secured an order from a customer for a Pre-Engineered Steel Building System for an Aircraft Hanger project at New Delhi, valued at Rs.67.56 Cr, with an approximate 8-month completion period.

Sambhv Steel Tubes Ltd has informed the exchange about the execution of a Material Services Agreement with Mr. Sachin Ramesh Tendulkar and SRT Sports Management Private Limited for the promotion, marketing, and advertisement of the company's steel products under the brand 'Sambhv' for a period of five years.

Dishman Carbogen Amcis Limited has informed BSE about Intimation on Agreements.

Dishman Carbogen Amcis Limited has informed BSE about Intimation on Agreements.

Dishman Carbogen Amcis Limited has informed BSE about Intimation on Agreements.

PAN HR SOLUTION LIMITED has informed BSE about Intimation on Agreements.

PAN HR SOLUTION LIMITED has informed BSE about Intimation on Agreements.

PAN HR SOLUTION LIMITED has informed BSE about Intimation on Agreements.

PAN HR SOLUTION LIMITED has informed BSE about Intimation on Agreements.

Venus Pipes & Tubes Limited has received an order worth Rs. 29 crore for pipe spooling from a data centre customer, forming part of the Rs. 185 crore Letter of Intent (LOI) received earlier. The order follows the commencement of operations at a part of the Company’s dedicated pipe spooling manufacturing facility.

Venus Pipes & Tubes Ltd has received an order worth Rs. 29 crore for pipe spooling from a data centre customer, forming part of the Rs. 185 crore Letter of Intent (LOI) received earlier. The company's expansion into pipe spooling represents an opportunity to broaden its value-added product portfolio and strengthen its participation in emerging industrial segments.

Venus Pipes & Tubes Limited has received an order worth Rs. 29 Crore for pipe spooling from a data centre customer, part of a Rs. 185 crore Letter of Intent (LOI) received earlier.

Venus Pipes & Tubes Ltd has received an order worth Rs. 29 Crore for pipe spooling from a data centre customer, part of a Rs. 185 crore Letter of Intent (LOI) received earlier.

Valplast Technologies Ltd has secured a new order/contract from M/s Nalanda Engicon Private Limited for Design, Supply, Erection, Testing and Commissioning of Power Supply Installations (PSI), including TSS, SP and SSP Works, worth ₹156,61,03,736.

Timken India Limited has received two Bureau of Indian Standards (BIS) licenses for its bearings, one for Spherical Roller Bearings at its Bharuch new plant and the other for Cylindrical Roller Bearings at its Bharuch old plant. This achievement confirms the company's leadership in manufacturing excellence, quality assurance, and regulatory compliance.

Timken India Ltd has received two BIS licenses for its bearings, one for Spherical Roller Bearings at its Bharuch new plant and the other for Cylindrical Roller Bearings at its Bharuch old plant. This achievement confirms the company's leadership in manufacturing excellence, quality assurance, and regulatory compliance.

Alembic Pharmaceuticals Ltd has received USFDA Final Approval for Venetoclax Tablets, 10mg, 50mg, and 100mg, which are indicated for the treatment of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and newly diagnosed acute myeloid leukemia (AML) in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.

Alembic Pharmaceuticals Limited has received USFDA Final Approval for Venetoclax Tablets, 10 mg, 50 mg and 100 mg, which are therapeutically equivalent to the reference listed drug product Venclexta Tablets, 10 mg, 50 mg, and 100 mg of AbbVie Inc. This approval may make Alembic eligible for 180 days of generic drug exclusivity and has a cumulative total of 248 ANDA approvals from the USFDA.